News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
318,198 Results
Type
Article (32069)
Company Profile (126)
Press Release (285999)
Multimedia
Podcasts (56)
Webinars (7)
Section
Business (79284)
Career Advice (443)
Deals (11588)
Drug Delivery (52)
Drug Development (51187)
Employer Resources (53)
FDA (6994)
Job Trends (6584)
News (146032)
Policy (11741)
Tag
2027 Biotech Bay Standard (2)
2027 Pharm Country Standard (1)
Academia (2252)
Academic (1)
Accelerated approval (21)
Adcomms (21)
Allergies (46)
Alliances (24463)
ALS (129)
Alzheimer's disease (1065)
Antibody-drug conjugate (ADC) (292)
Approvals (7165)
Artificial intelligence (260)
Autoimmune disease (123)
Automation (23)
Bankruptcy (76)
Best Places to Work (5739)
BIOSECURE Act (16)
Biosimilars (92)
Biotechnology (99)
Bladder cancer (119)
Brain cancer (48)
Breast cancer (480)
Cancer (4129)
Cardiovascular disease (174)
Career advice (403)
Career pathing (12)
CAR-T (297)
CDC (10)
Cell therapy (811)
Cervical cancer (30)
Clinical research (42054)
Collaboration (1056)
Company closure (3)
Compensation (303)
Complete response letters (29)
COVID-19 (1782)
CRISPR (81)
C-suite (472)
Cystic fibrosis (94)
Data (4146)
Denatured (11)
Depression (46)
Diabetes (200)
Diagnostics (3098)
Digital health (13)
Diversity (4)
Diversity, equity & inclusion (19)
Drug discovery (163)
Drug pricing (53)
Drug shortages (4)
Duchenne muscular dystrophy (127)
Earnings (25482)
Editorial (26)
Employer branding (6)
Employer resources (49)
Events (47969)
Executive appointments (474)
FDA (8661)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (9)
Frontotemporal dementia (19)
Funding (907)
Gene editing (163)
Generative AI (20)
Gene therapy (504)
GLP-1 (317)
Government (1966)
Grass and pollen (2)
Guidances (167)
Healthcare (8835)
HIV (28)
Huntington's disease (19)
IgA nephropathy (49)
Immunology and inflammation (160)
Immuno-oncology (47)
Indications (65)
Infectious disease (1907)
Inflammatory bowel disease (110)
Inflation Reduction Act (6)
Influenza (50)
Intellectual property (113)
Interviews (66)
IPO (5979)
IRA (20)
Job creations (1071)
Job search strategy (349)
JPM (35)
Kidney cancer (16)
Labor market (31)
Layoffs (255)
Leadership (12)
Legal (1767)
Liver cancer (69)
Longevity (11)
Lung cancer (652)
Lymphoma (379)
Machine learning (24)
Management (14)
Manufacturing (433)
MASH (61)
Medical device (3865)
Medtech (3886)
Mergers & acquisitions (6125)
Metabolic disorders (423)
Multiple sclerosis (114)
NASH (6)
Neurodegenerative disease (190)
Neuropsychiatric disorders (30)
Neuroscience (1755)
Neurotech (1)
NextGen: Class of 2026 (2735)
Non-profit (2426)
Now hiring (15)
Obesity (163)
Opinion (134)
Ovarian cancer (145)
Pain (79)
Pancreatic cancer (166)
Parkinson's disease (178)
Partnered (21)
Patents (215)
Patient recruitment (291)
Peanut (23)
People (27150)
Pharmaceutical (21)
Pharmacy benefit managers (2)
Phase 1 (15287)
Phase 2 (19144)
Phase 3 (12517)
Pipeline (2868)
Policy (119)
Postmarket research (1160)
Preclinical (7138)
Press Release (60)
Prostate cancer (167)
Psychedelics (26)
Radiopharmaceuticals (163)
Rare diseases (533)
Real estate (2207)
Recruiting (21)
Regulatory (10411)
Reports (22)
Research institute (2246)
Resumes & cover letters (52)
Rett syndrome (14)
RNA editing (11)
RSV (28)
Schizophrenia (61)
Series A (135)
Series B (98)
Service/supplier (2)
Sickle cell disease (104)
Special edition (8)
Spinal muscular atrophy (120)
Sponsored (22)
Startups (1946)
State (1)
Stomach cancer (16)
Supply chain (37)
Tariffs (22)
The Weekly (44)
Vaccines (570)
Venture capital (51)
Weight loss (71)
Women's health (28)
Worklife (7)
Date
Last 7 days (279)
Last 30 days (1003)
Last 365 days (15723)
2026 (1402)
2025 (16048)
2024 (18723)
2023 (21257)
2022 (27109)
2021 (28552)
2020 (25755)
2019 (20559)
2018 (15456)
2017 (15204)
2016 (14580)
2015 (17164)
2014 (12341)
2013 (10400)
2012 (10591)
2011 (10666)
2010 (9249)
Location
Africa (325)
Alabama (68)
Alaska (6)
Arizona (111)
Arkansas (5)
Asia (21069)
Australia (4205)
California (5693)
Canada (1426)
China (742)
Colorado (202)
Connecticut (195)
Delaware (219)
Europe (44922)
Florida (801)
Georgia (145)
Hawaii (2)
Idaho (28)
Illinois (389)
India (26)
Indiana (148)
Iowa (14)
Japan (270)
Kansas (41)
Kentucky (17)
Louisiana (7)
Maine (64)
Maryland (719)
Massachusetts (4507)
Michigan (89)
Minnesota (221)
Mississippi (2)
Missouri (55)
Montana (15)
Nebraska (9)
Nevada (49)
New Hampshire (23)
New Jersey (1650)
New Mexico (17)
New York (1699)
North Carolina (635)
North Dakota (9)
Northern California (2822)
Ohio (176)
Oklahoma (13)
Oregon (14)
Pennsylvania (1164)
Puerto Rico (7)
Rhode Island (23)
South America (427)
South Carolina (15)
Southern California (2154)
Tennessee (66)
Texas (1085)
United States (20599)
Utah (148)
Vermont (1)
Virginia (118)
Washington D.C. (44)
Washington State (595)
West Virginia (2)
Wisconsin (53)
318,198 Results for "harvard stem cell institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Stem Cell Specialist PrimeGen Takes SPAC Track to Nasdaq
The SPAC agreement values PrimeGen US at $1.5 billion in equity and gives it capital to advance its pre-clinical triple-activated mesenchymal stem cell pipeline into the clinic.
February 5, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Ayrmid Reports Additional New Real-World Data on Motixafortide for Stem Cell Mobilization in Sickle Cell Disease and Beta-Thalassemia
February 4, 2026
·
4 min read
Press Releases
Cellares to Expand Automated Manufacturing to Gene-Edited Stem Cell Therapies
February 4, 2026
·
3 min read
Press Releases
Michigan Integrative Health Expands Stem Cell Therapy Services to Welcome Canadian Patients
February 4, 2026
·
2 min read
Press Releases
ElpasBio and Fosun Kairos Announce Commercialization Collaboration for AlloJoin® Stem Cell Therapy
January 14, 2026
·
5 min read
Press Releases
Ayrmid Reports Promising New Real-World Data on Motixafortide for Stem Cell Mobilization in Sickle Cell Disease
December 8, 2025
·
3 min read
Press Releases
Longeveron® Granted Japan Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)
January 29, 2026
·
7 min read
Press Releases
Ayrmid Presents New Data on Motixafortide for Stem Cell Mobilization in Sickle Cell Disease
December 9, 2025
·
3 min read
Press Releases
Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant
February 5, 2026
·
4 min read
Press Releases
Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy
February 1, 2026
·
4 min read
1 of 31,820
Next
